Physician profile
Gary B Klein
NPI 1285732388
$791.04
in general payments reported to CMS, 2019-2025
13 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $92.82 · 2021: $62.81 · 2022: $181 · 2023: $136 · 2024: $75.06 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250 · Education: $82.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.86 |
| Education | $82.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $255.72 | 2021-2025 | Tremfya |
| Abbvie INC. | $141.02 | 2021-2024 | |
| Amgen INC. | $92.82 | 2020 | |
| Allergan, INC. | $67.10 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $44.58 | 2019-2021 | |
| Pfizer INC. | $33.60 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $30.53 | 2023 | Odomzo |
| Regeneron Healthcare Solutions, INC. | $30.04 | 2021-2025 | Libtayo |
| Biocon Biologics INC | $22.03 | 2025 | Yesintek |
| Pierre Fabre Pharmaceuticals, INC. | $21.00 | 2019 | |
| Lilly USA, LLC | $20.15 | 2022 | |
| Galderma Laboratories, L.P. | $16.93 | 2019 | |
| Novo Nordisk INC | $15.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.